Omada Health has announced five new senior hires, most notably a new chief medical officer, Dr. Paul Chew, who previously served as senior VP and global chief medical officer at Sanofi. The company also announced the hire of Tom Schoenherr as chief commercial officer, a position he previously held at Counsyl.
“For the last five years, we’ve worked to establish Omada Health as a leader in digital health, publishing clinically-validated results and operating on an outcomes-based revenue structure since Day One,” Omada Cofounder and CEO Sean Duffy said in a statement. “Bringing on Paul and Tom, experts in their fields with proven track records for clinical development and scaling healthcare businesses, is the next step in Omada’s evolution. Employers, payers, and health systems know digital health is here to stay, and the companies that will succeed are those that deliver outcomes and scale effectively. We’ve built a team to do exactly that.”
Three other senior hires rounded out the announcement. Dr. Carolyn Jasik, former VP of Medical Outcomes at Mango Health, will join Omada’s Medical Director. Rob Guigley and Mark Konopka, who also formerly worked at Counsyl, will both join Omada with the title of VP of Sales, with Guigley focusing on health plan and reimbursement strategy and Konopka focusing on employer and health system strategy.
Connected inhaler company Adherium also added a pharma vet to its executive team: Scott Fleming, Adherium's new VP of Business Development. Fleming successfully sold his cofounded company MicroDose to Teva Pharmaceuticals and became Global Brand Lead for eConnectivity of Teva's respiratory franchise.
"Bringing a pioneer of the digital health movement into our business is an exciting development as we continue to build our commercial capabilities, particularly in Europe," Adherium CEO Garth Sutherland said in a statement. "Scott's 25 years' experience in the field, combined with Adherium¹s leading expertise will ensure a compelling proposition for partners and customers."
Progyny, a digital health company that offers concierge fertility services, brought in former WebMD CEO David Schlanger as CEO last month. Now Peter Anevski, who served as WebMD chief financial officer under Schlanger, is also joining Progyny, as CFO and chief operating officer.
“I’m delighted to become a part of Progyny and resume my longstanding working relationship with CEO, David Schlanger," Anevski said in a statement. "It’s an exciting time to be at the company as it charts the next phase of growth in developing unique science-based and data-driven reproductive technology and in penetrating the employer market for fertility benefits."
Healthgrades, which offers online comparison tools for physicians and hospitals, has hired Eric Jensen as EVP of health systems products and strategy. Jensen previously served as COO and co-founder of Avia, a healthcare services company that helps health systems find and deploy digital solutions.
“The healthcare industry is rapidly changing with the focus moving more and more towards the consumer,” Scott Booker, CEO of Healthgrades, said in a statement. “Eric has significant experience working with health systems in evaluating their strategic challenges and working to formulate the right go-forward strategy. I am excited to add Eric to the Healthgrades leadership team. His strategic and analytical experience will ensure Healthgrades’ ability to make healthcare simpler for the consumer and healthcare provider.”
MyndBlue, a Boston-based mobile health company working on a wearable device for depression and PTSD, has added Nancy Briefs, a serial digital health entrepreneur, to its board of directors. Briefs has a 30-year career as an entrepreneur, CEO, and investor which includes cofounding digital health company Infobionic.
“We are extremely pleased that Nancy has joined our board,” MyndBlue Founder and CEO Dr. Denis Fompeyrine said in a statement. “She understands well that early-stage investors quickly comprehend the value proposition for MyndBlue, a potentially transformational paradigm for treating mental health disorders.”
The Council for Diabetes Prevention, a non-profit, membership-based coalition founded with the goal of increasing patient access to the National Diabetes Prevention Program and improving the quality and sustainability of the program, has elected its first board of directors. The members, who will each serve an initial term of one year, include Solera Health CEO and founder Brenda Schmidt; Marlayna Bollinger, executive director of the Skinny Gene Project; Dr. Neal Kaufman, Chief Medical Officer of Canary Health; Lark Technologies CEO Julia Hu; and Lisa Shaffer, SVP of industry relations for Blood Centers of America.
“We need all stakeholders to come together to solve the diabetes epidemic in America,” Anne Woodbury, executive director of the Council for Diabetes Prevention, said in a statement. “I’m looking forward to working with the diverse members of our board, who each bring their unique expertise, leadership and vision to help realize the mission of making the National DPP accessible to all Americans who need it.”